Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1972998 | 0.82 | DNM1 (0.33) | DNM1CA2MAPK1OPRM1 | |
| SCHEMBL21925359 | 0.77 | DNM1 (0.36) | DNM1CA2MAPK1OPRM1 | |
| SCHEMBL19049928 | 0.74 | CA2 (0.31) | DNM1CA2MAPK1OPRM1 | |
| SCHEMBL5074271 | 0.74 | OPRM1 (0.39) | DNM1CA2OPRM1 | |
| SCHEMBL24938316 | 0.73 | OPRM1 (0.37) | DNM1CA2MAPK1OPRM1 | |
| SCHEMBL11908384 | 0.72 | DNM1 (0.30) | DNM1 | |
| SCHEMBL6899437 | 0.71 | MAPT (0.30) | — | |
| SCHEMBL26237970 | 0.70 | DNM1 (0.35) | DNM1CA2OPRM1 | |
| SCHEMBL29219038 | 0.70 | OPRM1 (0.39) | DNM1CA2OPRM1 | |
| SCHEMBL25667858 | 0.70 | CA2 (0.31) | DNM1CA2MAPK1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2253626-B1 | THIETANE COMPOUND, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN, METHOD FOR PRODUCING THE RESIN, AND USE OF THE POLYMERIZABLE COMPOSITION AND THE RESIN | MITSUI CHEMICALS INC (JP) | 2013-05-29 | — | — | EP | disclosed |
| US-8362280-B2 | Thietane compound, polymerizable composition containing the same, resin, method for producing the resin, and use of the polymerizable composition and the resin | MITSUI CHEMICALS, INC. (JP) | 2013-01-29 | — | — | US | disclosed |
| US-20110118412-A1 | THIETANE COMPOUND, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN, METHOD FOR PRODUCING THE RESIN, AND USE OF THE POLYMERIZABLE COMPOSITION AND THE RESIN | MITSUI CHEMICALS, INC. (JP) | 2011-05-19 | — | — | US | disclosed |
| EP-2253626-A1 | THIETANE COMPOUND, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN, METHOD FOR PRODUCING THE RESIN, AND USE OF THE RESIN | Mitsui Chemicals, Inc. (JP) | 2010-11-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110118412-A1 | THIETANE COMPOUND, POLYMERIZABLE COMPOSITION CONTAINING THE SAME, RESIN, METHOD FOR PRODUCING THE RESIN, AND USE OF THE POLYMERIZABLE COMPOSITION AND THE RESIN | TERB1, TMSB10, TMSB4X | DNM1 3106/4885CA2 4571/4885MAPK1 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.